Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals

<p>Abstract</p> <p>Background</p> <p>Use of fenfluramines for weight loss has been associated with the development of characteristic plaques on cardiac valves causing regurgitation. However, previously published studies of exposure to fenfluramines have been limited by...

Full description

Bibliographic Details
Main Authors: Allen Marvin R, Dahl Charles F, Urie Paul M, Hopkins Paul N
Format: Article
Language:English
Published: BMC 2008-11-01
Series:BMC Medicine
Online Access:http://www.biomedcentral.com/1741-7015/6/34
id doaj-0c6c43c7982a4cea819111dc9f2dc60c
record_format Article
spelling doaj-0c6c43c7982a4cea819111dc9f2dc60c2020-11-25T01:39:17ZengBMCBMC Medicine1741-70152008-11-01613410.1186/1741-7015-6-34Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individualsAllen Marvin RDahl Charles FUrie Paul MHopkins Paul N<p>Abstract</p> <p>Background</p> <p>Use of fenfluramines for weight loss has been associated with the development of characteristic plaques on cardiac valves causing regurgitation. However, previously published studies of exposure to fenfluramines have been limited by relatively small sample size, short duration of follow-up, and the lack of any estimate of the frequency of subsequent valvular surgery. We performed an observational study of 5743 users of fenfluramines examined by echocardiography between July 1997 and February 2004 in a single large cardiology clinic.</p> <p>Results</p> <p>The prevalence of at least mild aortic regurgitation (AR) or moderate mitral regurgitation (MR) was 19.6% in women and 11.8% in men (<it>p </it>< 0.0001 for gender difference). Duration of use was strongly predictive of mild or greater AR (<it>p </it>< 0.0001 for trend), MR (<it>p </it>= 0.002), and tricuspid regurgitation (TR) (<it>p </it>< 0.0001), as was earlier scan date (<it>p </it>< 0.0001 for those scanned prior to 1 January 2000 versus later). Increasing age was also independently associated with increased risk of AR and MR (both <it>p </it>< 0.0001). With mean follow-up of 30.3 months, AR worsened in 15.2%, remained the same in 63.1%, and improved in 21.7%. Corresponding values for MR were 24.8%, 47.4% and 27.9%. Pulmonary hypertension was strongly associated with MR but not AR. Valve surgery was performed on 38 patients (0.66% of 5743), 25 (0.44%) with clear evidence of fenfluramine-related etiology.</p> <p>Conclusion</p> <p>Regurgitant valvulopathy was common in individuals exposed to fenfluramines, more frequent in females, and associated with duration of use in all valves assessed. Valve surgery was performed as frequently for aortic as mitral valves and some tricuspid valve surgeries were also performed. The incidence of surgery appeared to be substantially increased compared with limited general population data.</p> http://www.biomedcentral.com/1741-7015/6/34
collection DOAJ
language English
format Article
sources DOAJ
author Allen Marvin R
Dahl Charles F
Urie Paul M
Hopkins Paul N
spellingShingle Allen Marvin R
Dahl Charles F
Urie Paul M
Hopkins Paul N
Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
BMC Medicine
author_facet Allen Marvin R
Dahl Charles F
Urie Paul M
Hopkins Paul N
author_sort Allen Marvin R
title Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
title_short Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
title_full Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
title_fullStr Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
title_full_unstemmed Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
title_sort valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
publisher BMC
series BMC Medicine
issn 1741-7015
publishDate 2008-11-01
description <p>Abstract</p> <p>Background</p> <p>Use of fenfluramines for weight loss has been associated with the development of characteristic plaques on cardiac valves causing regurgitation. However, previously published studies of exposure to fenfluramines have been limited by relatively small sample size, short duration of follow-up, and the lack of any estimate of the frequency of subsequent valvular surgery. We performed an observational study of 5743 users of fenfluramines examined by echocardiography between July 1997 and February 2004 in a single large cardiology clinic.</p> <p>Results</p> <p>The prevalence of at least mild aortic regurgitation (AR) or moderate mitral regurgitation (MR) was 19.6% in women and 11.8% in men (<it>p </it>< 0.0001 for gender difference). Duration of use was strongly predictive of mild or greater AR (<it>p </it>< 0.0001 for trend), MR (<it>p </it>= 0.002), and tricuspid regurgitation (TR) (<it>p </it>< 0.0001), as was earlier scan date (<it>p </it>< 0.0001 for those scanned prior to 1 January 2000 versus later). Increasing age was also independently associated with increased risk of AR and MR (both <it>p </it>< 0.0001). With mean follow-up of 30.3 months, AR worsened in 15.2%, remained the same in 63.1%, and improved in 21.7%. Corresponding values for MR were 24.8%, 47.4% and 27.9%. Pulmonary hypertension was strongly associated with MR but not AR. Valve surgery was performed on 38 patients (0.66% of 5743), 25 (0.44%) with clear evidence of fenfluramine-related etiology.</p> <p>Conclusion</p> <p>Regurgitant valvulopathy was common in individuals exposed to fenfluramines, more frequent in females, and associated with duration of use in all valves assessed. Valve surgery was performed as frequently for aortic as mitral valves and some tricuspid valve surgeries were also performed. The incidence of surgery appeared to be substantially increased compared with limited general population data.</p>
url http://www.biomedcentral.com/1741-7015/6/34
work_keys_str_mv AT allenmarvinr valvularregurgitationandsurgeryassociatedwithfenfluramineuseananalysisof5743individuals
AT dahlcharlesf valvularregurgitationandsurgeryassociatedwithfenfluramineuseananalysisof5743individuals
AT uriepaulm valvularregurgitationandsurgeryassociatedwithfenfluramineuseananalysisof5743individuals
AT hopkinspauln valvularregurgitationandsurgeryassociatedwithfenfluramineuseananalysisof5743individuals
_version_ 1725049521862344704